Page last updated: 2024-08-23

tobramycin and lomefloxacin

tobramycin has been researched along with lomefloxacin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Weinstein, MP	1
Bonini, S; Bonomi, L; Bucci, MG; Bujtar, E; Colangelo, L; Curatola, MR; Damiani, S; Della Loggia, G; Gallenga, PE; Jauch, A; Lobefalo, L; Milan, E; Orzalesi, N; Pagliarusco, A; Palma, LA; Ponte, F; Tomazzoli Gerosa, L; Velati, P	1

Trials

1 trial(s) available for tobramycin and lomefloxacin

Article	Year
Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1999, Volume: 213, Issue:4 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Child; Colony Count, Microbial; Conjunctiva; Conjunctivitis, Bacterial; Double-Blind Method; Female; Fluoroquinolones; Follow-Up Studies; Haemophilus Infections; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Quinolones; Staphylococcal Infections; Streptococcal Infections; Tobramycin; Treatment Outcome	1999

Article

Year

Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1999, Volume: 213, Issue:4

Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Child; Colony Count, Microbial; Conjunctiva; Conjunctivitis, Bacterial; Double-Blind Method; Female; Fluoroquinolones; Follow-Up Studies; Haemophilus Infections; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Quinolones; Staphylococcal Infections; Streptococcal Infections; Tobramycin; Treatment Outcome

1999

Other Studies

2 other study(ies) available for tobramycin and lomefloxacin

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Comparative in vitro activity of lomefloxacin and other antimicrobials against 597 microorganisms causing bacteremia. Diagnostic microbiology and infectious disease, 1988, Volume: 11, Issue:4 Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Enoxacin; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Sepsis; Tobramycin	1988

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

Comparative in vitro activity of lomefloxacin and other antimicrobials against 597 microorganisms causing bacteremia.

Diagnostic microbiology and infectious disease, 1988, Volume: 11, Issue:4

Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Enoxacin; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Sepsis; Tobramycin

1988